From Submarines to Stillness: The Story behind Harmoniq's Science

What links submarines, cancer research experiments, and your mood?
The answer may surprise you. 

At a Glance

Harmoniq's FLOW wearable uses ulRFE (ultra-low radio frequency energy) to support energy shifts across states of calm, relief, sleep and performance.

It records the incredibly faint magnetic signature a molecule gives off, then plays it back through the FLOW as a gentle, drug-free magnetic field. The idea: if a compound's magnetic "signature" can be captured, some of its effect can be delivered without the compound itself.

The tech's development story is interesting, as it travelled a long road to get to you, from defence-grade magnetic sensors, through cancer research at EMulate Therapeutics, to our FLOW wearable.

The bottom line? The technology is real, researched and safe to wear; the FLOW's signals are based on compounds like caffeine, CBD and melatonin, supporting energy shifts without ingesting substances, and with positive feedback across hundreds of satisfied users.

Read on for the full story.

It began with an instrument built to find submarines

To detect a submarine hiding deep beneath the ocean, you have to sense the faintest trace it leaves behind, the tiny disturbance a steel hull makes in a magnetic field.

The tool built for that kind of job was the SQUID, a Superconducting Quantum Interference Device, an extremely sensitive magnetic-field detector. Cooled with liquid helium to operate at quantum limits, it can register tiny magnetic signals.

For years that quantum-grade sensitivity was pointed at the sea. Then someone pointed it at something far smaller: a single molecule in a drop of liquid.

Recording a molecule's signature

The idea at the heart of ulRFE is that solvated molecules, something as ordinary as caffeine or melatonin suspended in solution, are never still. As their electron clouds shift and the molecules rotate, they give off unique, hyper-faint electromagnetic fluctuations.

To capture one, the liquid is placed inside a heavily shielded chamber lined with SQUID magnetometers. Because a single molecule's magnetic signal sits almost at the thermodynamic noise floor, signal-processing algorithms strip away the ambient background to isolate the time-varying signature associated with the target compound.

The result? A digital file, a multi-frequency playback loop sometimes termed a biophysical "cognate."

Playing it back

Once a cognate is recorded, a wearable like the Harmoniq FLOW acts as a micro-transmitter, converting the file back into a real-time oscillating magnetic field, within tight technical bounds.

The output sits between 0 and 22 kHz, at the extreme low end of the spectrum despite the "radio frequency" name, and at an intensity measured in tens of milligauss (the research hardware is documented at an average of about 25 mG). At these levels the field is non-ionising and designed to operate non-thermally; studies to date report no tissue heating.

How it works

In classical pharmacology, a drug works by a "lock-and-key" mechanism: a physical molecule travels through the bloodstream, binds a receptor, and changes its shape, telling the cell to behave differently.

ulRFE proposes a different route to a similar end, delivering a molecule's magnetic signature rather than the molecule itself.

Preclinical evidence of biological activity included: a radio-frequency emulation of siRNA knocking down EGFR expression in glioblastoma cells, and an animal-behaviour study in which animals responded to ulRFE recordings of bioactive substances.

Essentially, the concept is that oscillating magnetic fields can induce tiny currents that affect ion channels, change how certain proteins bind, or shift cellular signalling. 

The breakthrough that proved it could reach the body

The science might have stayed a curiosity if not for a bolder question asked at EMulate Therapeutics: if you can record the signature of a compound's activity, could you broadcast it toward disease, without the drug?

Their focus was the blood-brain barrier. Many cancer drugs are too large to cross it, while a magnetic field passes through bone and tissue without significant attenuation.

EMulate built an investigational, head-worn device, the Voyager system, to broadcast recorded signatures toward brain tumours. In preclinical studies, a paclitaxel-inspired signal (A1A) promoted tubulin polymerisation and reduced tumour volumes in mouse glioblastoma models, and a signal recorded from siRNAs (A2) lowered immune-checkpoint expression.

In humans, the largest peer-reviewed study is an expanded safety and feasibility trial in 75 patients with recurrent glioblastoma, reported no serious device-related adverse events and described the technology as non-invasive, non-thermal and non-ionising.

What did this leg of the journey establish? That an ultra-low, drug-free magnetic field can be delivered to the human body and tolerated safely, with evidence of biological activity in laboratory models.

The arrival: The FLOW

To bring the platform out of the lab and into our everyday life, we streamlined it into the FLOW, a lightweight, wireless wearable. Because ulRFE works through a magnetic field rather than sound, there is nothing to hear and no headphones needed.

We scaled EMulate Therapeutics' complex, multimillion-dollar clinical technology down for consumer use, streamlining the hardware and delivery, and repackaging the clinical "cognate" signals into an accessible ecosystem built around The FLOW neckband and the Harmoniq App.

In clinical trials, patients wore bulky headgear or used stationary lab equipment. Harmoniq adapted this into The FLOW, a lightweight, flexible and wireless neckband.

• No headphones. Because ulRFE works through an oscillating magnetic field rather than sound, the neckband is completely silent and projects the field gently through the body.

• Versatile placement. Designed to sit at the neck, it can also be laid flat on a tired muscle for relief, or slipped under a pillow for sleep.

It rests at the base of the neck, and can also be laid against a tired muscle or slipped under a pillow. The FLOW's output is in the tens of milligauss, far weaker than the Earth's own magnetic field of roughly 500 mG, which surrounds you every moment of every day.

It is non-thermal, non-invasive and non-chemical. Nothing enters the bloodstream.

In place of clinical signatures, Harmoniq built a library of more than 25 everyday signals, grouped into four states:

• Calm — inspired by effect of CBD on body's natural down-regulators, designed to support a settled headspace.

• Sleep — inspired by the familiar wind-down associated with compounds like melatonin.

• Perform — inspired by the alert, focused feeling associated with compounds like caffeine.

• Relief — inspired by blended frequencies from things like CBD and melatonin amongst others, for soothing comfort.

The Harmoniq App pairs with the FLOW and integrates with Apple Health, Oura and WHOOP, with an inbuilt AI powered suggestion engine that recommends a session based on where your metrics sit.

A new kind of toolkit

For a century, changing how we feel has meant putting something into our bodies. Harmoniq is built on a different idea: that the body responds to signals as well as substances.

The science is real, and still unfolding. And the journey, from an instrument built to find submarines, through the frontier of cancer research, arrives, for now, with you. A platform that puts a new kind of control in your hands: over your energy, your calm, and how you meet the demands of modern life.

Give our FLOW a try today.